Table 3.
Relationship of LMP2, LMP7, TAP1, TAP2, and HLA Class I Antigen Expression in Primary Melanoma Lesions with Their Thickness
| Thickness (mm) | LMP2 | LMP7 | TAP1 | TAP2 | HLA Class I | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | +/− | − | + | +/− | − | + | +/− | − | + | +/− | − | + | +/− | − | ||
| <1.5 | no. | 1 | 7 | 1 | 6 | 3 | 0 | 6 | 3 | 1 | 4 | 6 | 0 | 6 | 4 | 0 |
| (%) | (11) | (78) | (11) | (67) | (33) | (0) | (60) | (30) | (10) | (40) | (60) | (0) | (60) | (40) | (0) | |
| 1.5–4.0 | no. | 14 | 5 | 1 | 14 | 6 | 0 | 14 | 9 | 2 | 13 | 10 | 2 | 12 | 12 | 1 |
| (%) | (70) | (25) | (5) | (70) | (30) | (0) | (56) | (36) | (8) | (52) | (40) | (8) | (48) | (48) | (4) | |
| >4.0 | no. | 3 | 8 | 9 | 7 | 11 | 2 | 9 | 7 | 9 | 9 | 7 | 9 | 7 | 8 | 10 |
| (%) | (15) | (40) | (45) | (35) | (55) | (10) | (36) | (28) | (36) | (36) | (28) | (36) | (28) | (32) | (40) |
+, positive (>75%); +/−, heterogeneous (25–75%); −, negative (<25%)